Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GADOVERSETAMIDE vs GANCICLOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GADOVERSETAMIDE vs GANCICLOVIR: Safety Overview

Metric GADOVERSETAMIDE GANCICLOVIR
Total FAERS Reports 286 4,990
Deaths Reported 5 1,469
Death Rate 1.7% 29.4%
Hospitalizations 11 1,735
Average Patient Age 45.7 yrs 41.7 yrs
% Female Patients 67.0% 41.5%
FDA Approval Date Dec 8, 1999 Dec 12, 1997
Manufacturer N/A Pharmascience Inc.
Route N/A INTRAVENOUS
Marketing Status Discontinued Discontinued